Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wallen

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Clinical Radiology|May 27, 2018
Integrative radiomics expression predicts molecular subtypes of primary clear cell renal cell carcinomaQ Yin, S-C Hung, W K Rathmell, et al.
The Journal of Urology|July 30, 2014
Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimateDavid C Johnson, Josip Vukina, Angela B Smith, et al.
BJU International|September 29, 2012
Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancerRonald C Chen, Julian G Rosenman, Leroy G Hoffman, et al.
Urologic Oncology|March 15, 2011
A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancerYoung E Whang, Andrew J Armstrong, W Kimryn Rathmell, et al.
The Journal of Urology|February 10, 2004
Immunological effects of granulocyte-macrophage colony-stimulating factor and autologous tumor vaccine in patients with renal cell carcinomaThomas Schwaab, Christopher P Tretter, Jennifer J Gibson, et al.
Urology Practice|December 29, 2023
Practice Readiness? Trends in Chief Resident Year Training Experience Across 13 Residency ProgramsZachary Corey, Erik Lehman, Gary E Lemack, et al.
Genes & Cancer|September 28, 2010
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival PatternsA Rose Brannon, Anupama Reddy, Michael Seiler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2016
Alternate Metabolic Programs Define Regional Variation of Relevant Biological Features in Renal Cell Carcinoma ProgressionSamira A Brooks, Amir H Khandani, Julia R Fielding, et al.
The Journal of Urology|September 20, 2015
Gender Differences in Compensation, Job Satisfaction and Other Practice Patterns in UrologyE Sophie Spencer, Allison M Deal, Nicholas R Pruthi, et al.
Urology|June 5, 2025
Trends in Urology Resident Surgical Autonomy: What Do ACGME Chief Resident Case Logs Indicate?Niccola B Lynch, Jonah Samuel, Zachary Corey, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Clinical Radiology|May 27, 2018
Integrative radiomics expression predicts molecular subtypes of primary clear cell renal cell carcinomaQ Yin, S-C Hung, W K Rathmell, et al.
The Journal of Urology|July 30, 2014
Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimateDavid C Johnson, Josip Vukina, Angela B Smith, et al.
BJU International|September 29, 2012
Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancerRonald C Chen, Julian G Rosenman, Leroy G Hoffman, et al.
Urologic Oncology|March 15, 2011
A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancerYoung E Whang, Andrew J Armstrong, W Kimryn Rathmell, et al.
The Journal of Urology|February 10, 2004
Immunological effects of granulocyte-macrophage colony-stimulating factor and autologous tumor vaccine in patients with renal cell carcinomaThomas Schwaab, Christopher P Tretter, Jennifer J Gibson, et al.
Urology Practice|December 29, 2023
Practice Readiness? Trends in Chief Resident Year Training Experience Across 13 Residency ProgramsZachary Corey, Erik Lehman, Gary E Lemack, et al.
Genes & Cancer|September 28, 2010
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival PatternsA Rose Brannon, Anupama Reddy, Michael Seiler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2016
Alternate Metabolic Programs Define Regional Variation of Relevant Biological Features in Renal Cell Carcinoma ProgressionSamira A Brooks, Amir H Khandani, Julia R Fielding, et al.
The Journal of Urology|September 20, 2015
Gender Differences in Compensation, Job Satisfaction and Other Practice Patterns in UrologyE Sophie Spencer, Allison M Deal, Nicholas R Pruthi, et al.
Urology|June 5, 2025
Trends in Urology Resident Surgical Autonomy: What Do ACGME Chief Resident Case Logs Indicate?Niccola B Lynch, Jonah Samuel, Zachary Corey, et al.
Pageof 15